Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $183.6 million.

  • HUTCHMED (China)'s Non-Current Assets fell 1363.78% to $183.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $775.3 million, marking a year-over-year increase of 24.54%. This contributed to the annual value of $67.6 million for FY2024, which is 862.6% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Non-Current Assets stood at $183.6 million, which was down 1363.78% from $67.6 million recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Non-Current Assets registered a high of $212.6 million during Q2 2024, and its lowest value of $67.6 million during Q4 2024.
  • For the 5-year period, HUTCHMED (China)'s Non-Current Assets averaged around $146.7 million, with its median value being $176.9 million (2021).
  • Per our database at Business Quant, HUTCHMED (China)'s Non-Current Assets soared by 2047.27% in 2021 and then tumbled by 1363.78% in 2025.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Non-Current Assets stood at $91.6 million in 2021, then fell by 12.6% to $80.1 million in 2022, then fell by 7.65% to $73.9 million in 2023, then fell by 8.63% to $67.6 million in 2024, then soared by 171.77% to $183.6 million in 2025.
  • Its Non-Current Assets was $183.6 million in Q2 2025, compared to $67.6 million in Q4 2024 and $212.6 million in Q2 2024.